Trial site
Komarom-Esztergom Varmegyei Szent Borbala Korhaz
- 27running trials
- 23closed trials
The trials here
What the 50 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Crohn's disease10 trials
- Ulcerative colitis10 trials
- Multiple sclerosis3 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Myeloproliferative neoplasms2 trials
- Prostate cancer2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- Colorectal cancer1 trial
- and 10 more
- Phase
- Phase 328 trials
- Phase 220 trials
- Phase 2/32 trials
- Status
- Completed22 trials
- Recruiting19 trials
- Active, not recruiting6 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Janssen Research & Development, LLC4 trials
- Amgen Inc.3 trials
- AstraZeneca3 trials
- GlaxoSmithKline3 trials
- and 21 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Recruiting
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Recruiting
Recruiting
Active, not recruiting
Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis6 recruiting
- Crohn's disease5 recruiting
- Lung cancer4 recruiting
- Multiple sclerosis2 recruiting
- Atrial fibrillation1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Completed
Completed
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Completed
Completed
Terminated
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Completed
Completed
Completed
Completed
Completed
Terminated
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026